Navigation Links
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results
Date:3/30/2009

encouraging clinical trial results to date, the commitment of its partner Auxilium to pursue the development of this indication and the future market opportunity for patients who do not have acceptable therapeutic alternatives.

In December 2008, BioSpecifics announced that its partner Auxilium signed a license agreement with Pfizer to market XIAFLEX(TM) in Europe and other territories for the treatment of Dupuytren's disease and Peyronie's disease and BioSpecifics negotiated certain modifications to its agreement with Auxilium in connection with that license agreement. As a result of such modifications, BioSpecifics received $6.375 million of the $75 million upfront payment paid to Auxilium by Pfizer, and will receive 8.5% of the $410 million in potential additional milestone payments that may be made by Pfizer to Auxilium. Of these additional milestone payments, $150 million are tied to regulatory milestones and $260 million are based on sales milestones. In addition, BioSpecifics will continue to receive milestone and royalty payments from Auxilium in accordance with its original agreement.

Recent Corporate Highlights

On January 6, 2009, BioSpecifics announced that it received notification from The NASDAQ Stock Market LLC that its common stock was approved for listing on the NASDAQ Global Market. BioSpecifics' common stock began trading on the Nasdaq Global Market under the ticker BSTC on January 9, 2009.

On February 2, 2009, Auxilium announced the completion of enrollment in a randomized, double-blind, placebo-controlled U.S. Phase IIb clinical trial in Peyronie's disease for XIAFLEX(TM). Due to the high level of interest from patients and physicians, Auxilium exceeded its enrollment target of 120 patients.

On February 3, 2009, BioSpecifics announced that it received an upfront sublicense payment of $6.375 million on January 30, 2009 from Auxilium in accordance
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
2. BioSpecifics Technologies Corp. to Present at Piper Jaffray 20th Annual Health Care Conference
3. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
4. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
5. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
6. BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering
7. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
8. BioSpecifics Technologies Corp. Announces Repayment of Outstanding Loan
9. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
10. BioSpecifics to Present at the 9th Annual Healthcare Conference of Acumen Bio Fin Rodman Renshaw LLC
11. Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: ... sustainable chemicals, today announced that the underwriters of its ... to purchase an additional 420,000 shares of common ... per share, less underwriting discounts and commissions, in ... of 2,800,000 shares of common stock, bringing the ...
(Date:7/23/2014)... Cord Blood Corporation (NYSE: CO ) ("CCBC" or the ... collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage ... to the mother and child segment, today announced that the two ... Singapore , Hong Kong , ... the Philippines and Malaysia to ...
(Date:7/23/2014)... July 23, 2014 Astra ... and comprehensive consultancy and pharma training services, and ... Safety (ACRES) , a non-profit integrating the expertise ... and maintain a global system for clinical trials, ... to improve the expertise of industry professionals through ...
(Date:7/22/2014)... a solution of rod-shaped metal nanoparticles in water with ... tiny drill bits. Why? No one yet knows exactly. ... Technology (NIST) have clocked their speedand it,s fast. At ... 10 times faster than any nanoscale object submerged in ... rate has opened up the possibility that they could ...
Breaking Biology Technology:BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 2China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 4Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2
... RIDGE, Tenn., Nov. 29, 2007 -- A water repellent ... Ridge National Laboratory outperforms nature at its best and ... super-water repellent (superhydrophobic) material, developed by John Simpson, is ... patent-pending process could lead to the creation of a ...
... CAMBRIDGE, Mass., Nov. 29 Merrimack Pharmaceuticals,Inc., a ... and,development of novel treatments for autoimmune disease and ... PhD from its Board of,Directors and the addition ... as a Director at Merrimack since May 2006. ...
... GRAND RAPIDS, Mich., Nov. 29 The Center ... the first member of the Xceed,Molecular (http://www.xceedmolecular.com ... role, CMM is the first US site to ... analysis, giving researchers an,important new tool in disease ...
Cached Biology Technology:ORNL super water repellent could cause big wave in market 2Merrimack Pharmaceuticals Announces the Addition of Robert Gay to its Board of Directors 2Merrimack Pharmaceuticals Announces the Addition of Robert Gay to its Board of Directors 3Center for Molecular Medicine Offers Xceed Ziplex(TM) Services to Research Community 2
(Date:7/23/2014)... tapeworms, hookworms and a protist called Blastocystis can ... that argues we should rethink our views of organisms that ... paper co-author Julius Luke even ingested three developmental stages of ... After more than a year with the tapeworms, which might ... by now, he says he feels fine. , "I knew ...
(Date:7/23/2014)... and rosemary are packed with healthful compounds, and now ... same way as prescription anti-diabetic medication, scientists report. In ... Agricultural and Food Chemistry , they found that how ... also identified which compounds contribute the most to this ... point out that in 2012, type-2 diabetes affected more ...
(Date:7/23/2014)... preconditioning has been confirmed by many studies, but ... released in the Neural Regeneration Research ... and co-workers from Tongji Hospital Affiliated to Tongji ... China performed cerebral ischemic preconditioning in rats by ... mechanism underlying the neuroprotective effect of ischemic preconditioning. ...
Breaking Biology News(10 mins):Intestinal parasites are 'old friends,' researchers argue 2Intestinal parasites are 'old friends,' researchers argue 3
... 2014   BioNano Genomics announced today the purchase of an ... projects, in completing the genome assembly of Aegilops tauschii, ... researchers at UC Davis, led by Dr. Jan Dvorak , ... the sequence, location, and orientation of all genes and transposable elements ...
... the genome might be important contributors to type 2 diabetes ... don,t encode proteins were once dismissed as "junk DNA", but ... controlling which genes are switched on. The new study, ... first to show how such regions, called regulatory elements, can ...
... Almost one in 10 people will someday experience a kidney ... pain imaginable. This increasingly common condition leads to hundreds of ... A new device developed at the University of Washington would ... body and help them pass by natural means. "Ultrasound ...
Cached Biology News:UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 2UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 3UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 4UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 5Non-coding DNA implicated in type 2 diabetes 2Trial to test using ultrasound to move kidney stones 2Trial to test using ultrasound to move kidney stones 3
... anti-phospho-PTEN (Ser385) ... amino acid region encompassing the ... (Ser385), Accession ... Quality Assurance: Routinely ...
Mouse monoclonal [YLI-90] to Ly49I (Biotin) ( Abpromise for all tested applications)....
TNR-R2...
Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: